Spots Global Cancer Trial Database for high dose methylprednisolone (hdmp)
Every month we try and update this database with for high dose methylprednisolone (hdmp) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL | NCT01496976 | Chronic Lymphoc... Small Lymphocyt... | High Dose Methy... Ofatumumab Lenalidomide | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | NCT01497496 | Chronic Lymphoc... Small Lymphocyt... | High Dose Methy... Ofatumumab Lenalidomide | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | NCT01497496 | Chronic Lymphoc... Small Lymphocyt... | High Dose Methy... Ofatumumab Lenalidomide | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |